502 related articles for article (PubMed ID: 10389953)
1. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
[TBL] [Abstract][Full Text] [Related]
2. Ketorolac for sickle cell vaso-occlusive crisis pain in the emergency department: lack of a narcotic-sparing effect.
Wright SW; Norris RL; Mitchell TR
Ann Emerg Med; 1992 Aug; 21(8):925-8. PubMed ID: 1497158
[TBL] [Abstract][Full Text] [Related]
3. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease.
Weiner DL; Hibberd PL; Betit P; Cooper AB; Botelho CA; Brugnara C
JAMA; 2003 Mar; 289(9):1136-42. PubMed ID: 12622584
[TBL] [Abstract][Full Text] [Related]
4. Intravenous ketorolac and subarachnoid opioid analgesia in the management of acute postoperative pain.
Gwirtz KH; Kim HC; Nagy DJ; Young JV; Byers RS; Kovach DA; Li W
Reg Anesth; 1995; 20(5):395-401. PubMed ID: 8519716
[TBL] [Abstract][Full Text] [Related]
5. Does Intravenous Acetaminophen Reduce Opioid Requirement in Pediatric Emergency Department Patients With Acute Sickle Cell Crises?
Dhebaria T; Sivitz A; Tejani C
Acad Emerg Med; 2021 Jun; 28(6):639-646. PubMed ID: 33025690
[TBL] [Abstract][Full Text] [Related]
6. Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness.
Beiter JL; Simon HK; Chambliss CR; Adamkiewicz T; Sullivan K
Arch Pediatr Adolesc Med; 2001 Apr; 155(4):496-500. PubMed ID: 11296078
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of pain control with ketorolac tromethamine in patients with sickle cell vaso-occlusive crisis.
Perlin E; Finke H; Castro O; Rana S; Pittman J; Burt R; Ruff C; McHugh D
Am J Hematol; 1994 May; 46(1):43-7. PubMed ID: 7514356
[TBL] [Abstract][Full Text] [Related]
8. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
[TBL] [Abstract][Full Text] [Related]
9. Use of ketorolac in sickle-cell disease and vaso-occlusive crisis.
Goodman E
Lancet; 1991 Sep; 338(8767):641-2. PubMed ID: 1679183
[No Abstract] [Full Text] [Related]
10. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
[TBL] [Abstract][Full Text] [Related]
11. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.
Nottage KA; Hankins JS; Faughnan LG; James DM; Richardson J; Christensen R; Kang G; Smeltzer M; Cancio MI; Wang WC; Anghelescu DL
Clin Trials; 2016 Aug; 13(4):409-16. PubMed ID: 27000103
[TBL] [Abstract][Full Text] [Related]
12. Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.
Baddam S; Aban I; Hilliard L; Howard T; Askenazi D; Lebensburger JD
Pediatr Nephrol; 2017 Aug; 32(8):1451-1456. PubMed ID: 28238158
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of ketorolac in children with forearm fractures.
Pierce MC; Fuchs S
Acad Emerg Med; 1997 Jan; 4(1):22-6. PubMed ID: 9110007
[TBL] [Abstract][Full Text] [Related]
14. Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches.
Seim MB; March JA; Dunn KA
Acad Emerg Med; 1998 Jun; 5(6):573-6. PubMed ID: 9660282
[TBL] [Abstract][Full Text] [Related]
15. Sickle cell vaso-occlusive pain crisis in adults: alternative strategies for management in the emergency department.
Sanders DY; Severance HW; Pollack CV
South Med J; 1992 Aug; 85(8):808-11. PubMed ID: 1302470
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ketorolac and morphine as adjuvants during pediatric surgery.
Watcha MF; Jones MB; Lagueruela RG; Schweiger C; White PF
Anesthesiology; 1992 Mar; 76(3):368-72. PubMed ID: 1539847
[TBL] [Abstract][Full Text] [Related]
17. Ketorolac versus acetaminophen-codeine in the emergency department treatment of acute low back pain.
Innes GD; Croskerry P; Worthington J; Beveridge R; Jones D
J Emerg Med; 1998; 16(4):549-56. PubMed ID: 9696169
[TBL] [Abstract][Full Text] [Related]
18. Postoperative pain after lumbar disc surgery: a comparison between parenteral ketorolac and narcotics.
Le Roux PD; Samudrala S
Acta Neurochir (Wien); 1999; 141(3):261-7. PubMed ID: 10214482
[TBL] [Abstract][Full Text] [Related]
19. Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.
Gillis JC; Brogden RN
Drugs; 1997 Jan; 53(1):139-88. PubMed ID: 9010653
[TBL] [Abstract][Full Text] [Related]
20. Intermittent injection vs patient-controlled analgesia for sickle cell crisis pain. Comparison in patients in the emergency department.
Gonzalez ER; Bahal N; Hansen LA; Ware D; Bull DS; Ornato JP; Lehman ME
Arch Intern Med; 1991 Jul; 151(7):1373-8. PubMed ID: 2064488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
